AU5253898A - Recombinant by55 and nucleic acids encoding same - Google Patents

Recombinant by55 and nucleic acids encoding same

Info

Publication number
AU5253898A
AU5253898A AU52538/98A AU5253898A AU5253898A AU 5253898 A AU5253898 A AU 5253898A AU 52538/98 A AU52538/98 A AU 52538/98A AU 5253898 A AU5253898 A AU 5253898A AU 5253898 A AU5253898 A AU 5253898A
Authority
AU
Australia
Prior art keywords
recombinant
nucleic acids
acids encoding
encoding same
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52538/98A
Inventor
Anukanth Anumanthan
Gordan J. Freeman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dana Farber Cancer Institute Inc
Original Assignee
Dana Farber Cancer Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Institute Inc filed Critical Dana Farber Cancer Institute Inc
Publication of AU5253898A publication Critical patent/AU5253898A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/04—Immunosuppressors, e.g. cyclosporin, tacrolimus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/52—CD40, CD40-ligand (CD154)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU52538/98A 1996-11-12 1997-11-12 Recombinant by55 and nucleic acids encoding same Abandoned AU5253898A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3052796P 1996-11-12 1996-11-12
US60030527 1996-11-12
US74785396A 1996-11-13 1996-11-13
US08747853 1996-11-13
PCT/US1997/020602 WO1998021240A1 (en) 1996-11-12 1997-11-12 Recombinant by55 and nucleic acids encoding same

Publications (1)

Publication Number Publication Date
AU5253898A true AU5253898A (en) 1998-06-03

Family

ID=26706139

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52538/98A Abandoned AU5253898A (en) 1996-11-12 1997-11-12 Recombinant by55 and nucleic acids encoding same

Country Status (2)

Country Link
AU (1) AU5253898A (en)
WO (1) WO1998021240A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1626059A1 (en) * 2004-08-09 2006-02-15 Institut National De La Sante Et De La Recherche Medicale (Inserm) Angiogenic and immunologic applications of anti-CD160 specific compounds obtainable from mAb CL1-R2
EP1880729A1 (en) * 2006-07-20 2008-01-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of soluble CD160 to suppress immunity
EP2006299A1 (en) * 2007-06-18 2008-12-24 Institut National De La Sante Et De La Recherche Medicale (Inserm) Identification of new isoforms of the MHC-class I specific receptor CD160 and uses thereof
WO2011047090A1 (en) * 2009-10-13 2011-04-21 Cedars-Sinai Medical Center Methods of diagnosing and monitoring rejection mediated by antibodies
CN102892432A (en) 2010-05-28 2013-01-23 国家医疗保健研究所 Anti-cd160 specific antibodies for the treatment of eye disorders based on neoangiogenesis
FR3061716B1 (en) 2017-01-06 2019-05-17 Elsalys Biotech NOVEL COMPOUNDS TARGETING CD160 HUMAN
CN113613664A (en) * 2019-03-01 2021-11-05 阿奇洛伊斯生物制药公司 Methods of modulating CD160 function in antigen-specific immune cells and uses thereof

Also Published As

Publication number Publication date
WO1998021240A1 (en) 1998-05-22

Similar Documents

Publication Publication Date Title
WO1999046281A8 (en) Novel polypeptides and nucleic acids encoding the same
AU4234997A (en) Secreted proteins and polynucleotides encoding them
AU3381797A (en) Secreted proteins and polynucleotides encoding them
AU2179197A (en) Novel phytase and gene encoding said phytase
EP0948651A4 (en) Recombinant n-smases and nucleic acids encoding same
AU6667998A (en) Nucleic acids encoding caspase-8h and caspase-8i
AU3890797A (en) Secreted proteins and polynucleotides encoding them
AU2486300A (en) Secreted proteins and nucleic acids encoding them
AU5706198A (en) Secreted proteins and polynucleotides encoding them
AU6280899A (en) Secreted proteins and nucleic acids encoding them
AU3810097A (en) Secreted proteins and polynucleotides encoding them
AU1909900A (en) Polypeptides having lactonohydrolase activity and nucleic acids encoding same
AU5253898A (en) Recombinant by55 and nucleic acids encoding same
AU2459397A (en) Secreted proteins and polynucleotides encoding them
AU1290499A (en) Actin-binding polypeptides and nucleic acids encoding the same
AU2728697A (en) Secreted proteins and polynucleotides encoding them
AU5256298A (en) Secreted proteins and polynucleotides encoding them
AU5840300A (en) Glutx polypeptide family and nucleic acids encoding same
AU5516498A (en) Secreted proteins and polynucleotides encoding them
AU3986497A (en) Secreted proteins and polynucleotides encoding them
AU3721397A (en) Secreted proteins and polynucleotides encoding them
AU3597097A (en) Secreted proteins and polynucleotides encoding them
AU3721597A (en) Secreted proteins and polynucleotides encoding them
AU4077597A (en) Secreted proteins and polynucleotides encoding them
AU4167997A (en) Enzyme and dna sequence encoding same